K. Boeck, S. Hofmann, M. Klopfer, U. Ian, and T. Schmidt, Melanoma-associated paraneoplastic retinopathy: case report and review of the literature, Br J Dermatol, vol.137, pp.457-460, 1997.

E. L. Berson and S. Lessell, Paraneoplastic night blindness with malignant melanoma, Am J Ophthalmol, vol.106, pp.307-311, 1988.

Y. Lu, L. Jia, S. He, M. C. Hurley, and M. J. Leys, Melanoma-associated retinopathy: a paraneoplastic autoimmune complication, Arch Ophthalmol, vol.127, pp.1572-1580, 2009.

E. Rahimy and D. Sarraf, Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management, Surv Ophthalmol, vol.58, pp.430-458, 2013.

J. W. Chan, Paraneoplastic retinopathies and optic neuropathies, Surv Ophthalmol, vol.48, pp.12-38, 2003.

C. E. Thirkill, P. Fitzgerald, R. C. Sergott, A. M. Roth, and N. K. Tyler, Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells, N Engl J Med, vol.321, pp.1589-1594, 1989.

C. E. Thirkill, A. M. Roth, and J. L. Keltner, Cancer-associated retinopathy, Arch Ophthalmol, vol.105, pp.372-375, 1987.

A. M. Canamary, W. Y. Takahashi, and J. Sallum, Autoimmune retinopathy: A Review, Int J Retina Vitreous, vol.4, p.29340169, 2018.

K. R. Alexander, G. A. Fishman, N. S. Peachey, A. L. Marchese, and M. O. Tso, On' response defect in paraneoplastic night blindness with cutaneous malignant melanoma, Invest Ophthalmol Vis Sci, vol.33, pp.477-483, 1992.

M. Kondo, R. Sanuki, S. Ueno, Y. Nishizawa, and N. Hashimoto, Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction, PLoS One, vol.6, 2011.

G. Goetgebuer, A. M. Kestelyn-stevens, D. Laey, J. J. Kestelyn, P. Leroy et al., Cancer-associated retinopathy (CAR) with electronegative ERG: a case report, Doc Ophthalmol, vol.116, p.17721792, 2008.

A. Anastasakis, A. D. Dick, E. M. Damato, P. G. Spry, and M. A. Majid, Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction, Doc Ophthalmol, vol.123, p.21674222, 2011.

J. F. Remulla, R. Pineda, A. R. Gaudio, and A. H. Milam, Cutaneous melanoma-associated retinopathy with retinal periphlebitis, Arch Ophthalmol, vol.113, pp.854-855, 1995.

K. Murayama, H. Takita, Y. Kiyohara, Y. Shimizu, and T. Tsuchida, , 2006.

, Nippon Ganka Gakkai Zasshi, vol.110, pp.211-217

J. L. Keltner, C. E. Thirkill, and P. T. Yip, Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases, J Neuroophthalmol, vol.21, pp.173-187, 2001.

P. Roberts, G. A. Fishman, K. Joshi, and L. M. Jampol, Chorioretinal Lesions in a Case of Melanoma-Associated Retinopathy Treated With Pembrolizumab, JAMA Ophthalmol, vol.134, pp.1184-1188, 2016.

G. Schubert and H. Bornschein, Analysis of the human electroretinogram, Ophthalmologica, vol.123, pp.396-413, 1952.

Y. Miyake, K. Yagasaki, M. Horiguchi, Y. Kawase, and T. Kanda, Congenital stationary night blindness with negative electroretinogram. A new classification, Arch Ophthalmol, vol.104, pp.1013-1020, 1986.

C. Zeitz, A. G. Robson, and I. Audo, Congenital stationary night blindness: an analysis and update of genotype-phenotype correlations and pathogenic mechanisms, Prog Retin Eye Res, vol.45, pp.58-110, 2015.

D. L. Mcculloch, M. F. Marmor, M. G. Brigell, R. Hamilton, and G. E. Holder, ISCEV Standard for fullfield clinical electroretinography (2015 update), Doc Ophthalmol, vol.130, pp.1-12, 2015.

I. Audo, S. Kohl, B. P. Leroy, F. L. Munier, and X. Guillonneau, TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness, Am J Hum Genet, vol.85, pp.720-729, 2009.

A. Dhingra, M. E. Fina, A. Neinstein, D. J. Ramsey, and Y. Xu, Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells, J Neurosci, vol.31, pp.3962-3967, 2011.

Y. Wang, M. S. Abu-asab, W. Li, M. E. Aronow, and A. D. Singh, Autoantibody against transient receptor potential M1 cation channels of retinal ON bipolar cells in paraneoplastic vitelliform retinopathy, BMC Ophthalmol, vol.12, p.23148706, 2012.

W. H. Xiong, R. M. Duvoisin, G. Adamus, B. G. Jeffrey, and C. Gellman, Serum TRPM1 autoantibodies from melanoma associated retinopathy patients enter retinal on-bipolar cells and attenuate the electroretinogram in mice, PLoS One, vol.8, p.69506, 2013.

S. Ueno, K. M. Nishiguchi, H. Tanioka, A. Enomoto, and T. Yamanouchi, Degeneration of retinal on bipolar cells induced by serum including autoantibody against TRPM1 in mouse model of paraneoplastic retinopathy, PLoS One, vol.8, p.81507, 2013.

M. D. Dalal, C. W. Morgans, R. M. Duvoisin, E. A. Gamboa, and B. G. Jeffrey, Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing: a novel approach, Ophthalmology, vol.120, pp.2560-2564, 2013.

Y. Morita, K. Kimura, Y. Fujitsu, A. Enomoto, and S. Ueno, Autoantibodies to transient receptor potential cation channel, subfamily M, member 1 in a Japanese patient with melanoma-associated retinopathy, Jpn J Ophthalmol, vol.58, p.24468869, 2014.

S. Ueno, Y. Ito, R. Maruko, M. Kondo, and H. Terasaki, Choroidal atrophy in a patient with paraneoplastic retinopathy and anti-TRPM1 antibody, Clin Ophthalmol, vol.8, pp.369-373, 2014.

S. Ueno, A. Nakanishi, K. Nishi, S. Suzuki, and H. Terasaki, Case of paraneoplastic retinopathy with retinal ON-bipolar cell dysfunction and subsequent resolution of ERGs, Doc Ophthalmol, vol.130, p.25391361, 2015.

R. M. Duvoisin, T. L. Haley, G. Ren, I. Strycharska-orczyk, and J. P. Bonaparte, Autoantibodies in Melanoma-Associated Retinopathy Recognize an Epitope Conserved Between TRPM1 and TRPM3, Invest Ophthalmol Vis Sci, vol.58, pp.2732-2738, 2017.

D. Roels, S. Ueno, C. D. Talianu, D. Draganova, and M. Kondo, Unilateral cancer-associated retinopathy: diagnosis, serology and treatment, Doc Ophthalmol, vol.135, p.28815346, 2017.

S. Ueno, D. Inooka, A. Nakanishi, S. Okado, and S. Yasuda, Clinical Course of Paraneoplastic Retinopathy with Anti-Trpm1 Autoantibody in Japanese Cohort, 2018.

R. M. Duvoisin, G. Ren, T. L. Haley, M. H. Taylor, and C. W. Morgans, TRPM1 Autoantibodies in Melanoma Patients Without Self-Reported Visual Symptoms, vol.60, pp.2330-2335, 2019.

S. Touhami, I. Audo, C. Terrada, A. Gaudric, and P. Lehoang, Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis, Prog Retin Eye Res, vol.72, p.100761, 2019.

B. Lei, R. A. Bush, A. H. Milam, and P. A. Sieving, Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo, Invest Ophthalmol Vis Sci, vol.41, pp.262-266, 2000.

K. M. Nishiguchi, K. Fujita, T. Inoue, and T. Nakazawa, Anti-TRPM1 antibodies in patients with retinal degeneration, Clin Exp Ophthalmol, vol.46, pp.1087-1089, 2018.

A. S. Polans, D. Witkowska, T. L. Haley, D. Amundson, and L. Baizer, Recoverin, a photoreceptorspecific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy, Proc Natl Acad Sci U S A, vol.92, pp.9176-9180, 1995.

J. Mazar, K. Deyoung, D. Khaitan, E. Meister, and A. Almodovar, The regulation of miRNA-211 expression and its role in melanoma cell invasiveness, PLoS One, vol.5, p.13779, 2010.

C. Levy, M. Khaled, D. Iliopoulos, M. M. Janas, and S. Schubert, Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma, Mol Cell, vol.40, pp.841-849, 2010.

G. M. Boyle, S. L. Woods, V. F. Bonazzi, M. S. Stark, and E. Hacker, Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor, Pigment Cell Melanoma Res, vol.24, p.21435193, 2011.

S. Zhiqi, M. H. Soltani, K. M. Bhat, N. Sangha, and D. Fang, Human melastatin 1 (TRPM1) is regulated by MITF and produces multiple polypeptide isoforms in melanocytes and melanoma, Melanoma Res, vol.14, pp.509-516, 2004.

D. Fang and V. Setaluri, Expression and Up-regulation of alternatively spliced transcripts of melastatin, a melanoma metastasis-related gene, in human melanoma cells, Biochem Biophys Res Commun, vol.279, pp.53-61, 2000.

I. Audo, A. Friedrich, S. Mohand-said, L. M. Antonio, and A. , An unusual retinal phenotype associated with a novel mutation in RHO, Arch Ophthalmol, vol.128, pp.1036-1045, 2010.

Y. Cao, E. Posokhova, and K. A. Martemyanov, TRPM1 forms complexes with nyctalopin in vivo and accumulates in postsynaptic compartment of ON-bipolar neurons in mGluR6-dependent manner, J Neurosci, vol.31, pp.11521-11526, 2011.

E. Enninga, J. C. Moser, A. L. Weaver, S. N. Markovic, and J. D. Brewer, Survival of cutaneous melanoma based on sex, age, and stage in the United States, Cancer Med, vol.6, pp.2203-2212, 1992.

T. E. Robsahm, G. Bergva, U. E. Hestvik, and B. Moller, Sex differences in rising trends of cutaneous malignant melanoma in Norway, Melanoma Res, vol.23, pp.70-78, 2013.

G. Adamus, G. Ren, and R. G. Weleber, Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy, BMC Ophthalmol, vol.4, 2004.

D. S. Grewal, G. A. Fishman, and L. M. Jampol, Autoimmune retinopathy and antiretinal antibodies: a review, Retina, vol.34, pp.827-845, 2014.

G. Adamus and L. Karren, Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy, J Autoimmun, vol.32, pp.133-139, 2009.